Literature DB >> 7705699

Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment.

W K Kinney1, D O Hodge, E V Egorshin, D J Ballard, K C Podratz.   

Abstract

Because of the well-documented morbidity of radical hysterectomy, it would appear desirable to isolate a subset of patients at low risk of parametrial spread or disease recurrence who might thereby be candidates for less radical surgical therapy. To this end, the records of all patients undergoing radical hysterectomy for cervical carcinoma at our institution between 1956 and 1985 were reviewed. Of the 387 patients treated for squamous carcinoma clinically confined to the cervix, 83 (21.4%) had tumors with depth of invasion greater than 3 mm (stage IB) but volume of tumor less than or equal to that of a sphere 2 cm in diameter (4.19 cm3) and no tumor in angiolymphatic spaces. Of the 83 patients, none had parametrial nodal metastasis. Median follow-up of this subgroup was 9.8 years, and the Kaplan-Meier estimate of 5-year disease-free survival was 97.6% (95% confidence interval, 94.3-100%). We consider patients in the subset described above to be candidates for modified radical hysterectomy and pelvic lymphadenectomy, with a decrease in morbidity associated with the less radical dissection, a low risk of failure to excise occult parametrial tumor, and the expectation of an excellent chance of long-term disease-free survival.

Entities:  

Mesh:

Year:  1995        PMID: 7705699     DOI: 10.1006/gyno.1995.1091

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  24 in total

1.  Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer.

Authors:  Yong An Chung; Sung Hoon Kim; Hyung Sun Sohn; Soo Kyo Chung; Chae Chun Rhim; Sung Eun Namkoong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-05-22       Impact factor: 9.236

Review 2.  Early Cervical Cancer: Current Dilemmas of Staging and Surgery.

Authors:  Tiffany Zigras; Genevieve Lennox; Karla Willows; Allan Covens
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

3.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

4.  2017 Update on the Querleu-Morrow Classification of Radical Hysterectomy.

Authors:  Denis Querleu; David Cibula; Nadeem R Abu-Rustum
Journal:  Ann Surg Oncol       Date:  2017-08-07       Impact factor: 5.344

Review 5.  Early cervical neoplasia: advances in screening and treatment modalities.

Authors:  Brent Tierney; Shannon N Westin; Matthew P Schlumbrecht; Pedro T Ramirez
Journal:  Clin Adv Hematol Oncol       Date:  2010-08

6.  Cervical cancer in pregnant women: treat, wait or interrupt? Assessment of current clinical guidelines, innovations and controversies.

Authors:  Sileny N Han; Mina Mhallem Gziri; Kristel Van Calsteren; Frédéric Amant
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

7.  Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy?

Authors:  Ashlee L Smith; Michael Frumovitz; Kathleen M Schmeler; Ricardo dos Reis; Alpa M Nick; Robert L Coleman; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2010-08-12       Impact factor: 5.482

Review 8.  Management of low-risk early-stage cervical cancer: should conization, simple trachelectomy, or simple hysterectomy replace radical surgery as the new standard of care?

Authors:  Pedro T Ramirez; Rene Pareja; Gabriel J Rendón; Carlos Millan; Michael Frumovitz; Kathleen M Schmeler
Journal:  Gynecol Oncol       Date:  2013-09-14       Impact factor: 5.482

9.  "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer.

Authors:  Michael Frumovitz; Elizabeth D Euscher; Michael T Deavers; Pamela T Soliman; Kathleen M Schmeler; Pedro T Ramirez; Charles F Levenback
Journal:  Gynecol Oncol       Date:  2012-08-19       Impact factor: 5.482

10.  Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.

Authors:  Jill H Tseng; Alessia Aloisi; Yukio Sonoda; Ginger J Gardner; Oliver Zivanovic; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2018-07       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.